Reduction of the metallochromic indicators murexide and tetramethylmurexide to their free radical metabolites by cytoplasmic enzymes and reducing agents.
Murexide underwent reduction by rat liver cytosolic fraction or a hypoxanthine-xanthine oxidase system to produce a free radical metabolite. Reduction of murexide by the freshly prepared cytosolic fraction depended upon the presence of ascorbic acid. N1-Methylnicotinamide, xanthine or hypoxanthine, in that order, could also serve as a source of reducing equivalents for the production of that free radical by the cytosolic fraction. Several thiol compounds (GSH, cysteine, and cysteamine), pyridine nucleotides (NADH, NADPH) and ascorbic acid were also effective in generating the murexide-derived free radical. Tetramethyl murexide was also reduced to its free radical derivative by a hypoxanthine-xanthine oxidase system.
D000818:Animals; D001205:Ascorbic Acid / Q000494:pharmacology; D001463:Barbiturates / Q000378:metabolism*; D003545:Cysteine / Q000494:pharmacology; D003600:Cytosol / Q000201:enzymology; D004578:Electron Spin Resonance Spectroscopy; D005609:Free Radicals; D005978:Glutathione / Q000494:pharmacology; D008099:Liver / Q000201:enzymology*; D008297:Male; D009114:Murexide / Q000031:analogs & derivatives / Q000378:metabolism*; D010084:Oxidation-Reduction / Q000187:drug effects*; D010101:Oxygen Consumption / Q000187:drug effects; D051381:Rats; D014969:Xanthine Oxidase / Q000378:metabolism*
D001463:Barbiturates; D005609:Free Radicals; C026042:tetramethylmurexide; D009114:Murexide; D014969:Xanthine Oxidase; D005978:Glutathione; D003545:Cysteine; D001205:Ascorbic Acid